SG11201701600QA - Probes for imaging huntingtin protein - Google Patents
Probes for imaging huntingtin proteinInfo
- Publication number
- SG11201701600QA SG11201701600QA SG11201701600QA SG11201701600QA SG11201701600QA SG 11201701600Q A SG11201701600Q A SG 11201701600QA SG 11201701600Q A SG11201701600Q A SG 11201701600QA SG 11201701600Q A SG11201701600Q A SG 11201701600QA SG 11201701600Q A SG11201701600Q A SG 11201701600QA
- Authority
- SG
- Singapore
- Prior art keywords
- probes
- huntingtin protein
- imaging
- imaging huntingtin
- protein
- Prior art date
Links
- 102000016252 Huntingtin Human genes 0.000 title 1
- 108050004784 Huntingtin Proteins 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
- 239000000523 sample Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- High Energy & Nuclear Physics (AREA)
- Theoretical Computer Science (AREA)
- Pulmonology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462043603P | 2014-08-29 | 2014-08-29 | |
| PCT/US2015/047407 WO2016033445A1 (en) | 2014-08-29 | 2015-08-28 | Probes for imaging huntingtin protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201701600QA true SG11201701600QA (en) | 2017-03-30 |
Family
ID=55400648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201701600QA SG11201701600QA (en) | 2014-08-29 | 2015-08-28 | Probes for imaging huntingtin protein |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US10479802B2 (en) |
| EP (2) | EP3186233B8 (en) |
| JP (2) | JP6817207B2 (en) |
| KR (2) | KR102586736B1 (en) |
| CN (2) | CN116655618B (en) |
| AU (1) | AU2015308774B2 (en) |
| BR (1) | BR112017004141B8 (en) |
| CA (1) | CA2959501C (en) |
| DK (1) | DK3186233T3 (en) |
| EA (1) | EA035646B1 (en) |
| ES (1) | ES2898965T3 (en) |
| HR (1) | HRP20211778T1 (en) |
| HU (1) | HUE056957T2 (en) |
| IL (1) | IL250803B (en) |
| MX (2) | MX380810B (en) |
| PL (1) | PL3186233T3 (en) |
| PT (1) | PT3186233T (en) |
| SG (1) | SG11201701600QA (en) |
| SI (1) | SI3186233T1 (en) |
| WO (1) | WO2016033445A1 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10907197B2 (en) | 2014-08-29 | 2021-02-02 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| PT3186241T (en) | 2014-08-29 | 2021-01-08 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| CA2959501C (en) | 2014-08-29 | 2023-10-10 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| KR102410733B1 (en) | 2014-08-29 | 2022-06-20 | 씨에이치디아이 파운데이션, 인코포레이티드 | Probes for imaging huntingtin protein |
| RU2721419C2 (en) | 2015-08-28 | 2020-05-19 | СиЭйчДиАй ФАУНДЕЙШН, ИНК. | Probing proteins of hentingin protein |
| RU2766139C2 (en) | 2016-03-11 | 2022-02-08 | Ац Иммуне Са | Bicyclic compounds for diagnostics and treatment |
| CN107056723A (en) * | 2017-04-21 | 2017-08-18 | 云南大学 | It is a kind of that there is the compound for suppressing vascular endothelial growth factor receptor signal transduction |
| CA3075892C (en) | 2017-09-14 | 2024-01-23 | Daiichi Sankyo Company, Limited | Heterocyclic compounds for the treatment and/or prevention of inflammatory diseases |
| WO2019201921A1 (en) | 2018-04-20 | 2019-10-24 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
| SG11202012150UA (en) | 2018-06-08 | 2021-01-28 | Ac Immune Sa | Novel compounds for diagnosis |
| ES2974634T3 (en) | 2018-12-21 | 2024-06-28 | Celgene Corp | Thienopyridine inhibitors of RIPK2 |
| US11389438B2 (en) | 2019-02-25 | 2022-07-19 | Chdi Foundation, Inc. | Compounds for targeting mutant huntingtin protein and uses thereof |
| CN111635400A (en) | 2019-03-02 | 2020-09-08 | 察略盛医药科技(上海)有限公司 | Pyrazolo[1,5-a]pyridine derivatives, preparation method and use thereof |
| US11992535B2 (en) * | 2019-12-18 | 2024-05-28 | Chdi Foundation, Inc. | Compounds and probes for imaging huntingtin protein |
| CN115209952B (en) | 2020-01-13 | 2025-05-30 | 维基分析有限公司 | Substituted pyrazolopyrimidines and their uses |
| CA3175602A1 (en) | 2020-05-07 | 2021-11-11 | Jerome Molette | Novel compounds for diagnosis |
| US12036292B2 (en) * | 2020-08-06 | 2024-07-16 | Chdi Foundation, Inc. | Heterobiaryl compounds and imaging agents for imaging huntingtin protein |
| CN117412960A (en) * | 2021-04-08 | 2024-01-16 | Chdi基金会股份有限公司 | Isoindolinone Compounds and Imaging Agents for Imaging Huntingtin Protein |
| CN117545512A (en) * | 2021-04-27 | 2024-02-09 | Chdi基金会股份有限公司 | Deuterated compounds and imaging agents for imaging huntingtin |
| AU2022306297A1 (en) | 2021-07-09 | 2024-02-08 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
| US20250034149A1 (en) | 2021-11-10 | 2025-01-30 | Ac Immune Sa | Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis |
| AU2022385416A1 (en) | 2021-11-10 | 2024-05-02 | Ac Immune Sa | 4h-imidazo[1,5-b]pyrazole derivatives for diagnosis |
| US20250042905A1 (en) | 2021-11-10 | 2025-02-06 | Ac Immune Sa | Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis |
| TW202425965A (en) | 2022-09-30 | 2024-07-01 | 日商科研製藥股份有限公司 | Condensed ring compound and pharmaceuticals containing thereof |
| EP4634191A1 (en) | 2022-12-16 | 2025-10-22 | AC Immune SA | Novel compounds for diagnosis |
| WO2024126840A1 (en) | 2022-12-16 | 2024-06-20 | Ac Immune Sa | Novel compounds for diagnosis |
| TW202500134A (en) * | 2023-05-18 | 2025-01-01 | 美商恩維達醫療公司 | G-protein coupled receptor antagonist |
| WO2025037013A1 (en) | 2023-08-16 | 2025-02-20 | Ac Immune Sa | Diagnostic compounds that bind to alpha-synuclein |
| WO2025106920A1 (en) * | 2023-11-15 | 2025-05-22 | Yale University | Parp pet imaging agents and methods of using the same |
| CN119264072B (en) * | 2024-12-06 | 2025-05-02 | 国科大杭州高等研究院 | Fluorescent probe for cell imaging and its synthesis method and application |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985755A (en) | 1972-06-02 | 1976-10-12 | E. R. Squibb & Sons, Inc. | Pyridine containing isothiocyanobenzoxazoles |
| US4198416A (en) | 1976-09-30 | 1980-04-15 | Meiji Seika Kaisha, Ltd. | 5-Alkoxy-picolinic esters and anti-hypertensive composition containing 5-alkoxy-picolinic esters |
| DE2909754A1 (en) * | 1979-03-13 | 1980-09-18 | Thomae Gmbh Dr K | Benzofuranyl:oxy or benzothienyl:oxy substd. alkanoic acid derivs. - with hypolipidaemic activity, useful as anti-atherosclerosis agents |
| FR2524468B1 (en) | 1982-04-06 | 1985-10-18 | Sandoz Sa | NOVEL CONDENSED THIOPHENE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS OPTICAL BRIGHTENERS |
| JP2869561B2 (en) * | 1989-05-22 | 1999-03-10 | 大塚製薬株式会社 | Platelet adhesion inhibitor |
| US5041453A (en) | 1990-05-30 | 1991-08-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 |
| JP2600644B2 (en) * | 1991-08-16 | 1997-04-16 | 藤沢薬品工業株式会社 | Thiazolyl benzofuran derivative |
| GB9203798D0 (en) * | 1992-02-21 | 1992-04-08 | Fujisawa Pharmaceutical Co | Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| WO1994022846A1 (en) * | 1993-03-30 | 1994-10-13 | Pfizer Inc. | Compounds enhancing antitumor activity of other cytotoxic agents |
| GB9317949D0 (en) * | 1993-08-28 | 1993-10-13 | Stevens Malcolm F G | Benzothiazole compounds |
| PT729956E (en) | 1995-02-28 | 2002-03-28 | Lilly Co Eli | INTERMEDIATE COMPOUNDS FORMULATIONS AND METHODS OF BENZOTIOPHENE |
| JPH08325265A (en) * | 1995-05-29 | 1996-12-10 | Fujisawa Pharmaceut Co Ltd | Production of thiazolylbenzofuran derivative, and compound used for the production |
| EP0880519B1 (en) | 1996-01-22 | 2002-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| JPH11171886A (en) | 1997-12-08 | 1999-06-29 | Mitsui Chem Inc | Pyprolylbenzimidazole derivative having amidine or guanidine in side chain |
| US6573264B1 (en) * | 2000-10-23 | 2003-06-03 | Cv Therapeutics, Inc. | Heteroaryl alkyl piperazine derivatives |
| EP1452530A4 (en) * | 2001-12-03 | 2005-11-30 | Japan Tobacco Inc | Azole compound and medicinal use thereof |
| IL162243A0 (en) | 2001-12-20 | 2005-11-20 | Wyeth Corp | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| CA2438032C (en) | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| US20070053831A1 (en) | 2003-05-20 | 2007-03-08 | Barrio Jorge R | Methods for binding agents to b-amyloid plaques |
| AU2003304416A1 (en) | 2003-08-13 | 2005-03-07 | Bf Research Institute, Inc. | Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| TW200616974A (en) | 2004-07-01 | 2006-06-01 | Astrazeneca Ab | Chemical compounds |
| CN101384555A (en) | 2006-02-15 | 2009-03-11 | 塞诺菲-安万特股份有限公司 | Novel aminoalcohol-substituted aryldihydroisoquinolinones, processes for their preparation and their use as medicaments |
| BRPI0716583A2 (en) * | 2006-08-24 | 2013-10-01 | Australian Nuclear Science Tec | fluorinated ligands to label peripheral benzodiazepine receptors |
| JP5190893B2 (en) * | 2006-12-25 | 2013-04-24 | 国立大学法人東北大学 | Benzoxazole derivatives |
| US7858803B2 (en) * | 2007-04-27 | 2010-12-28 | The General Hospital Corporation | Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders |
| KR101469275B1 (en) | 2007-06-01 | 2014-12-08 | 재단법인서울대학교산학협력재단 | Heterocyclic indene derivatives and their radioisotope labeled compounds for imaging β-amyloid deposition |
| WO2009042907A1 (en) | 2007-09-27 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| US20090123373A1 (en) * | 2007-11-05 | 2009-05-14 | Yanming Wang | Amyloid-imaging agents |
| US8153813B2 (en) | 2007-12-20 | 2012-04-10 | Abbott Laboratories | Benzothiazole and benzooxazole derivatives and methods of use |
| WO2009146388A1 (en) | 2008-05-28 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Voxel-based methods for assessing subjects using positron emission tomography |
| US20110076230A1 (en) * | 2008-05-30 | 2011-03-31 | Barrow James C | Novel Substituted Indoles |
| WO2009155017A2 (en) * | 2008-05-30 | 2009-12-23 | Merck & Co., Inc. | Novel substituted azabenzoxazoles |
| WO2010051196A1 (en) * | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel substituted azabenzoxazoles |
| US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| PL2414369T3 (en) | 2009-04-02 | 2016-04-29 | Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii | Imidazo[2,1-b][1,3,4]thiadiazole derivatives |
| GB0905664D0 (en) * | 2009-04-02 | 2009-05-13 | Summit Corp Plc | Compounds for treatment of duchenne muscular dystrophy |
| ES2620177T3 (en) | 2009-10-15 | 2017-06-27 | Guerbet | Imaging agents and their use for in vivo diagnosis of neurodegenerative diseases, particularly Alzheimer's disease and derived diseases |
| JP2011168515A (en) | 2010-02-17 | 2011-09-01 | Kowa Co | 2-arylbenzoxazole compound having erythropoietin production-promoting action |
| WO2012007510A1 (en) * | 2010-07-14 | 2012-01-19 | Bayer Pharma Aktiengesellschaft | Compounds for binding and imaging amyloid plaques and their use |
| JP5824517B2 (en) | 2010-11-30 | 2015-11-25 | 武田薬品工業株式会社 | Bicyclic compound |
| CN102391260B (en) * | 2011-09-29 | 2014-12-10 | 上海交通大学 | 3-Methanone-6-substituted-benzofuran compound and its preparation method and use |
| SG11201406759YA (en) * | 2012-04-26 | 2014-11-27 | Bristol Myers Squibb Co | Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
| US9370588B2 (en) * | 2013-01-04 | 2016-06-21 | University Of Massachusetts | Luciferin amides |
| GB201306248D0 (en) * | 2013-04-05 | 2013-05-22 | Ucl Business Plc | Compounds and their uses |
| CA2917267C (en) * | 2013-07-17 | 2021-12-28 | Otsuka Pharmaceutical Co., Ltd. | Cyanotriazole compounds |
| CA2959501C (en) * | 2014-08-29 | 2023-10-10 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| KR102410733B1 (en) | 2014-08-29 | 2022-06-20 | 씨에이치디아이 파운데이션, 인코포레이티드 | Probes for imaging huntingtin protein |
| US10907197B2 (en) | 2014-08-29 | 2021-02-02 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| PT3186241T (en) | 2014-08-29 | 2021-01-08 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| RU2721419C2 (en) | 2015-08-28 | 2020-05-19 | СиЭйчДиАй ФАУНДЕЙШН, ИНК. | Probing proteins of hentingin protein |
-
2015
- 2015-08-28 CA CA2959501A patent/CA2959501C/en active Active
- 2015-08-28 ES ES15836321T patent/ES2898965T3/en active Active
- 2015-08-28 WO PCT/US2015/047407 patent/WO2016033445A1/en not_active Ceased
- 2015-08-28 MX MX2017002703A patent/MX380810B/en unknown
- 2015-08-28 HU HUE15836321A patent/HUE056957T2/en unknown
- 2015-08-28 CN CN202310475134.8A patent/CN116655618B/en active Active
- 2015-08-28 PT PT158363218T patent/PT3186233T/en unknown
- 2015-08-28 DK DK15836321.8T patent/DK3186233T3/en active
- 2015-08-28 JP JP2017530971A patent/JP6817207B2/en active Active
- 2015-08-28 SG SG11201701600QA patent/SG11201701600QA/en unknown
- 2015-08-28 EP EP15836321.8A patent/EP3186233B8/en active Active
- 2015-08-28 KR KR1020227035965A patent/KR102586736B1/en active Active
- 2015-08-28 SI SI201531751T patent/SI3186233T1/en unknown
- 2015-08-28 KR KR1020177008383A patent/KR102456946B1/en active Active
- 2015-08-28 PL PL15836321T patent/PL3186233T3/en unknown
- 2015-08-28 EP EP21192872.6A patent/EP4006016A3/en not_active Withdrawn
- 2015-08-28 BR BR112017004141A patent/BR112017004141B8/en active IP Right Grant
- 2015-08-28 HR HRP20211778TT patent/HRP20211778T1/en unknown
- 2015-08-28 AU AU2015308774A patent/AU2015308774B2/en active Active
- 2015-08-28 EA EA201790407A patent/EA035646B1/en unknown
- 2015-08-28 CN CN201580058282.3A patent/CN107108534B/en active Active
- 2015-08-28 US US15/507,208 patent/US10479802B2/en active Active
-
2017
- 2017-02-27 IL IL250803A patent/IL250803B/en active IP Right Grant
- 2017-02-28 MX MX2021003311A patent/MX2021003311A/en unknown
-
2019
- 2019-08-02 US US16/530,594 patent/US11059836B2/en active Active
-
2020
- 2020-12-24 JP JP2020214504A patent/JP7126541B2/en active Active
-
2022
- 2022-08-05 US US17/881,895 patent/US12258355B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250803B (en) | Probes for imaging huntingtin protein | |
| GB201417164D0 (en) | Measurement Probe | |
| IL250805B (en) | Probes for imaging huntingtin protein | |
| GB201413245D0 (en) | ImAGE Analysis | |
| IL250804A0 (en) | Probes for imaging huntingtin protein | |
| IL250802A0 (en) | Probes for imaging huntingtin protein | |
| GB201500641D0 (en) | Ultrasound probe | |
| EP3197341A4 (en) | Probe for iridocorneal angle imaging | |
| IL257537B (en) | Probes for imaging huntingtin protein | |
| IL259034B (en) | Probe cover | |
| SG11201606516RA (en) | Probe unit | |
| SG11201702178TA (en) | Probe unit | |
| GB2533151B (en) | Improved probe | |
| HK40110855A (en) | Probes for imaging huntingtin protein | |
| GB2550120B (en) | Probe | |
| GB201517390D0 (en) | Protein variant analysis | |
| HK1240583A1 (en) | Probes for imaging huntingtin protein | |
| HK1241224A1 (en) | Probes for imaging huntingtin protein | |
| GB201407787D0 (en) | Imaging techniques |